SAVI Dual Alternatives

SAVI Dual uses single-pulse transcranial magnetic stimulation (sTMS) for migraine treatment, but its monthly rental cost and prescription requirement may be important access and cost considerations for people comparing non-invasive neuromodulation devices. Several alternatives provide drug-free migraine relief through different device formats, stimulation targets, access models, and pricing structures. This guide examines five SAVI Dual alternatives at a high level, focusing on practical comparison points such as placement, prescription status, age indication, treatment format, and cost.

Key Takeaways

• Cefaly offers the lowest total cost of ownership among the dual-mode migraine devices discussed here, with a one-time purchase of $509 plus electrode refills
• Only two devices are available without a prescription: Cefaly and HeadaTerm 2, making prescription status a major access difference across device options
• Device placement varies significantly: Cefaly targets the trigeminal nerve through forehead placement, Nerivio uses an upper-arm band, gammaCore stimulates the vagus nerve at the neck, and Relivion MG uses a headset-style format
• Age indications differ across devices: Cefaly is FDA-cleared for adults 18 and older, while Nerivio is approved for ages 8 and up, and gammaCore and SAVI Dual are cleared for ages 12 and older
• Treatment session lengths range widely: gammaCore sessions take 2 minutes, SAVI Dual pulses complete in under 1 minute, while Cefaly’s Prevent mode runs 20 minutes and Acute mode runs 60 minutes

1. Cefaly

Cefaly stands as the first FDA-cleared external trigeminal nerve stimulation (e-TNS) device for migraine. The device uses precise electrical impulses delivered through an electrode positioned on the forehead, between and just above the eyebrows, to calm the trigeminal nerve, the primary pathway for migraine pain.

Key Features

• Dual treatment modes: Acute mode uses 60-minute sessions during migraine attacks, and Prevent mode uses 20-minute daily sessions for preventive treatment.
• No prescription required: Available without a prescription in the U.S., Canada, the EU, and other countries.
• Device ownership model: One-time purchase at $509 with a 3-year warranty and no ongoing subscription fee for the device itself.
• Bluetooth connectivity: The Cefaly device pairs with the Cefaly Migraine Relief app for treatment tracking and health wearables integration where available.
• Refund-specific satisfaction guarantee: Directthe official website purchasers may return the device for a refund within 90 calendar days of product delivery.

Evidencia clínica

Cefaly’s effectiveness is supported by multiple randomized controlled trials:

• ACME study: 79% of patients experienced significant headache pain reduction after one hour of acute treatment.
• TEAM study: 56.4% of patients resolved their most bothersome migraine symptom after two hours, with 67.3% achieving nausea resolution.
• PREMICE study: 32.7% decrease in monthly headache days after three months of compliant preventive treatment.

2. Nerivio

Best For: People comparing a prescription upper-arm device format with a pediatric age indication

Access: Prescription required

Treatment Format: Smartphone-controlled remote electrical neuromodulation device worn on the upper arm

Nerivio uses remote electrical neuromodulation (REN) through an upper-arm wearable. This format differs from forehead-based devices because the device is worn away from the head, which may be an important practical consideration for people comparing device placement during migraine attacks.

What Makes It Stand Out

• Upper-arm placement: Nerivio is worn on the upper arm rather than on the forehead, neck, or around the head.
• App-controlled operation: Treatment is managed through a smartphone app.
• Broad age indication: Nerivio is FDA-cleared for patients 8 years and older, which distinguishes it from adult-only devices.
• 45-minute treatment sessions: The device uses 45-minute sessions for acute and preventive use.

3. gammaCore

Best For: People comparing a prescription neck-based device with a cluster headache indication

Access: Prescription required

Treatment Format: Non-invasive vagus nerve stimulation device applied to the side of the neck

gammaCore uses non-invasive vagus nerve stimulation (nVNS), applying electrical stimulation to the vagus nerve through the skin of the neck. The device holds FDA clearance for migraine and cluster headache, making its cluster headache indication a key comparison point for people reviewing neuromodulation device formats.

What Makes It Stand Out

• Neck-based application: gammaCore stimulates the vagus nerve at the side of the neck.
• Short treatment sessions: Treatment uses 2-minute stimulations, typically performed in a prescribed sequence.
• Cluster headache indication: gammaCore has an FDA-cleared cluster headache indication, which distinguishes it from migraine-only device comparisons.
• Ages 12 and older: gammaCore is discussed as an adolescent and adult device option.

4. Relivion MG

Best For: People comparing a headset-style device format that stimulates both trigeminal and occipital nerves

Access: Prescription required

Treatment Format: Headset-style external combined occipital and trigeminal neurostimulation device

Relivion MG uses external combined occipital and trigeminal neurostimulation (eCOT-NS), targeting multiple nerve pathways through a headset-style device. It received FDA clearance for acute migraine treatment in 2021 and is generally discussed as an acute-use device rather than a dual acute-and-preventive option.

What Makes It Stand Out

• Multi-nerve targeting: Relivion MG stimulates both trigeminal and occipital nerves.
• Headset design: The device is worn around the head during treatment sessions.
• 20- to 60-minute sessions: Session length varies within the acute-use format.
• Acute treatment focus: Relivion MG is not FDA-cleared for preventive migraine treatment.

5. HeadaTerm 2

Best For: People comparing a lower-cost, non-prescription forehead device format

Access: Over-the-counter

Treatment Format: Forehead-based transcutaneous electrical nerve stimulation device

HeadaTerm 2 received FDA clearance in 2024 and uses transcutaneous electrical nerve stimulation for migraine relief. Like Cefaly, it does not require a prescription, making access status one of its main comparison points.

What Makes It Stand Out

• No prescription required: HeadaTerm 2 is available over the counter.
• Forehead electrode placement: The device uses forehead placement, similar in general placement area to Cefaly.
• Adults 18 and older: Its age indication aligns with adult-use migraine device comparisons.
• Lower upfront cost positioning: HeadaTerm 2 is often compared as a budget-oriented OTC option.

Understanding How Neuromodulation Treats Migraine

Neuromodulation devices work by delivering controlled electrical or magnetic impulses to specific nerves involved in migraine pathophysiology. This approach offers a drug-free treatment format rather than a systemic medication format.

The Science Behind Trigeminal Nerve Stimulation

The trigeminal nerve is the primary pathway for migraine pain, transmitting pain signals from the face and head to the brain. E-TNS devices like Cefaly deliver precise electrical impulses through the skin to calm trigeminal nerve endings.

This stimulation is generally discussed in relation to:

• Nerve excitability during migraine attacks.
• Pain signal transmission.
• Preventive-use patterns when used regularly according to device instructions.

For more background, understanding how Cefaly works can help explain the forehead-based e-TNS mechanism.

Drug-Free Device Format Considerations

Non-pharmacological migraine devices are often compared because they offer a drug-free treatment format. Key considerations include:

• Drug-free device format: Cefaly does not add another medication to a treatment routine.
• Localized treatment format: Cefaly uses external stimulation at the forehead rather than a systemic drug.
• Medication-use context: People with medication questions or medication changes should discuss their migraine care plan with a healthcare provider.
• Individualized clinical considerations: Talk to your healthcare provider before using Cefaly if you are pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms. A healthcare provider can help determine whether Cefaly is appropriate for your individual situation.

Device Comparison Summary

Cefaly’s key comparison points include:

• Lowest long-term cost among the dual acute-and-preventive devices discussed here.
• No prescription requirement
• Both acute and preventive treatment in one device
• Forehead-based e-TNS device format
• HSA/FSA eligibility
• A satisfaction guarantee that allows direct purchasers to return the device for a refund within 90 calendar days of product delivery

Other devices may be relevant for people comparing:

• A prescription upper-arm format with a pediatric age indication, as with Nerivio
• A prescription neck-based format with a cluster headache indication, as with gammaCore
• A prescription headset-style acute-use format, as with Relivion MG
• A lower-cost OTC forehead device format, as with HeadaTerm 2

For direct website purchases, Cefaly offers a satisfaction guarantee that allows returns for a refund within 90 calendar days of product delivery.

Preguntas frecuentes

What is the primary difference between Acute and Prevent mode on e-TNS devices like Cefaly?

Acute mode delivers 60-minute treatment sessions designed for use during an active migraine attack. Prevent mode uses 20-minute daily sessions at a different stimulation pattern for preventive treatment. Clinical studies show that consistent use of Prevent mode produced a 32.7% decrease in monthly headache days after three months.

How does the Cefaly device compare to SAVI Dual in terms of total cost?

Cefaly costs $509 as a one-time purchase plus approximately $25 to $37 monthly for electrode refills, totaling roughly $689 to $868 in the first year and decreasing in subsequent years. SAVI Dual operates on a $395 monthly rental subscription, totaling $4,740 annually. Over three years, Cefaly costs approximately $1,289 to $1,756 compared to $14,220 for SAVI Dual. Cefaly also offers device ownership, meaning the device is purchased rather than rented.

Can neuromodulation devices be used during pregnancy?

Talk to your healthcare provider before using Cefaly or any neuromodulation device if you are pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms. A healthcare provider can help determine whether a specific device is appropriate for your individual situation.

How often do Cefaly adhesive electrodes need to be replaced?

Each Cefaly electrode can be used for approximately 20 sessions when properly cared for. Electrode care generally includes washing the forehead with soap and water before each session, handling electrodes by the edges, replacing them on the plastic backing after use, and storing them sealed in their pouch. Electrodes are available in standard and hypoallergenic formulations, sold in packs of three. A subscription service offers a 5% discount with customizable delivery every 30, 60, or 90 days.

What contraindications should I be aware of before using Cefaly?

Cefaly should not be used by individuals with metallic or electronic implants in the head, cardiac pacemakers, or implanted or wearable defibrillators. The device should not be used on pain of unknown origins. Review the complete list of contraindications in the user manual or contact Cefaly with specific questions about your situation.